ERBB2 and breast carcinoma: Finally of note, despite characterizing several snoRNAs with likely prognostic value to breast cancer using the same data sets we utilized to identify the correlation between sdRNA-93 and the Luminal B Her2+breast tumor subtype depicted in Fig. 6, the initial analyses performed by Krishnan et al.26 did not identify any significant correlation between snoRNA-93 expression and breast malignancy.